Exclusive: Twin Health, metabolic health startup, raises $53 million Series E at $950 million valuation | Fortune
Summary
Twin Health raised $53 million in Series E funding at a valuation above $950 million. The company uses a digital twin model to help patients manage metabolic disease by combining data from glucose monitors, activity trackers, and behavior coaching. New study results published with Cleveland Clinic showed strong clinical outcomes, including lower A1C levels and medication reductions among participants. The company plans to use the capital to scale commercially with more employers, health plans, and patients.
Funding
Amount
$53.0M
Total raised
Date
August 21, 2025
Announcement date
Investors
Temasek Holdings, Cleveland Clinic
Lead investors
Company
twinhealth.com
Funded company
Classifications
industries
HealthTech
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected